CRIO’s chief innovation officer, Mike Wenger touches on the two ways sites get AI adoption wrong.
|Articles|March 1, 2010
- Applied Clinical Trials-03-01-2010
- Volume 0
- Issue 0
Applied Clinical Trials Digital Edition - March 2010
REGULATORY : Rediscovering the Role of Regulatory Scientists CRO/SPONSOR : Trends in Clinical Outsourcing Language Lessons for Global Sponsors SITES : The ABCs of SOP Best Practices Also in this issue : FDA Works to Modernize Health IT System, Health Technology Assessment Brews in EU, Sizing Up the Clinical Research Market, Patients Tune In to Recruitment
Advertisement
Articles in this issue
over 16 years ago
Applied Clinical Trials Digital Edition - March 2010, Supplementover 16 years ago
The State of Clinical Outsourcingover 16 years ago
SOPs: A Must for Sitesover 16 years ago
Business and People Update March 2010over 16 years ago
Health IT Promises Timely Drug Informationover 16 years ago
RA Market, Small But Fierceover 16 years ago
Putting Patients Firstover 16 years ago
EU Trials Come Under Securityover 16 years ago
Translating for Sponsorsover 16 years ago
Sizing Up the Clinical Research MarketAdvertisement
Related to this article
CRIO’s Mike Wenger, speaker at this year's SCRS summit, maps how sites are actually deploying AI post-pilot stage.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, explains why the real advantage of faster data isn’t speed—it’s shortening the distance between signals, human judgment, and the next best action.
In today’s ACT Brief, we examine how AI is moving into continuous clinical operating models, how trust is built into oncology real-world evidence, and how the FDA approved a self-administered option for thyroid eye disease.
Paradigm’s Kurt Mussina discusses why scale should drive operational efficiency, not consolidation into single-site studies.
Paradigm’s Kurt Mussina touches on why he rejects the “site management organization” model in favor of one unified business.
ProofPilot’s Lauren Briggs talks on why sponsors and CROs fail at tech rollouts by skipping change management, and pushes for the industry to judge trial technology by real workflow impact rather than feature checklists.
ProofPilot’s Lauren Briggs touches on why site tech adoption hinges on the first 90 days after rollout, and why tools succeed only when they remove work from a site’s plate rather than adding another login to juggle.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
2026 SCRS Global Site Solutions Summit: What Should Sponsors and CROs Change About How They Contract with a Network?
2
What It Actually Means to Embed AI Across the Clinical Operating Model
3
2026 SCRS Global Site Solutions Summit: What's the Biggest Policy Gap Delaying Integrated, Community-Based Research Being the Norm?
4
2026 SCRS Global Site Solutions Summit: What's a Mistake Sponsors or CROs Make When Rolling Out New Trial Technology?
5